Finance
Results: 11365-11376 of 49209

Velocys Unlocks More Than 30% Cost Reduction for microFTL Technology Deployment Through Standardisation and Delivery Efficiencies, Helps Advance Two Flagship FT SAF Projects

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis








